Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Valcrest Pharmaceuticals

Valcrest Pharmaceuticals
2015 FOUNDED
PRIVATE STATUS
Angel LATEST DEAL TYPE
$50K LATEST DEAL AMOUNT
Description

Developer of pharmaceutical products for treating ultra-rare orphan diseases. The company specializes in the development and commercialization of pharmaceutical products to address the needs of patients with ultra-rare orphan diseases.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • 809-B Cuesta Drive
  • Suite 196
  • Mountain View, CA 94040
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Valcrest Pharmaceuticals’s full profile, request a free trial.

Valcrest Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 27-Mar-2015 $50K 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Valcrest Pharmaceuticals Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sandoz Corporate Backed or Acquired Holzkirchen, Germany 00000 00000000000
000000-00000 00000 Corporate Backed or Acquired Maple Grove, MN 000000&0
00000000 Corporate Backed or Acquired Dublin, Ireland 0000 000000&0
00000000000 000000 Private Equity-Backed Mexico City, Mexico 000.00 0000000000 000.00
0000000 0000000000 Formerly VC-backed Cambridge, MA 000 00000 000000 - 000 00000
To view this company’s complete list of competitors, request access »

Valcrest Pharmaceuticals Executive Team (2)

Name Title Board
Seat
Contact
Info
Kenneth Greathouse Chief Executive Officer
Brian Smith President and Manager